Nalaganje...
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood volume, cardiac...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3340112/ https://ncbi.nlm.nih.gov/pubmed/22563249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S30005 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|